🇺🇸 Isentress. in United States

7,182 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anxiety — 935 reports (13.02%)
  2. Pain — 881 reports (12.27%)
  3. Foetal Exposure During Pregnancy — 815 reports (11.35%)
  4. Emotional Distress — 780 reports (10.86%)
  5. Depression — 757 reports (10.54%)
  6. Anhedonia — 700 reports (9.75%)
  7. Maternal Exposure During Pregnancy — 618 reports (8.6%)
  8. Exposure During Pregnancy — 598 reports (8.33%)
  9. Drug Interaction — 578 reports (8.05%)
  10. Chronic Kidney Disease — 520 reports (7.24%)

Source database →

Isentress. in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Isentress. approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Isentress. in United States?

McGill University Health Centre/Research Institute of the McGill University Health Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.